image: Insilico Medicine scientists will present the advances in deep learning in biomedicine at the ISFA-Columbia University Actuarial Science Workshop on June 27th and 28th in Lyon, France. view more
Credit: Insilico Medicine
Insilico Medicine scientists to present the advances in deep learning in biomedicine at the ISFA-Columbia University Actuarial Science Workshop on June 27th and 28th in Lyon, France. Actuarial science is one of the disciplines, which deals with population-level big data to assess risk in finance, insurance, pensions and many other industries. In recent years advances in deep learning fuelled by the availability of big data and high-performance GPU computing enabled algorithms achieve superhuman accuracy in many tasks including image, voice and text recognition, autonomous driving, playing video games and complex games like Go. However, these advances have not yet propagated into mainstream use by the actuaries and ISFA-Columbia University Workshop may set the stage for Deep Actuarial Science.
"Actuaries are perhaps among the least famous scientists and do not frequently make headlines, but these scientists are making the world's economy tick. Actuaries are in charge of building mortality tables, where one decimal point may result in trillions of dollars in liabilities and sophisticated risk models with global impact. We are very happy to present at ISFA events because the organizers are not only top experts in the field, but also have a vision for bringing new technologies and concepts into both the actuarial and longevity science", said Alex Zhavoronkov, PhD, CEO of Insilico Medicine, Inc.
INSTITUT DE SCIENCE FINANCIERE ET D'ASSURANCES (ISFA) established in 1930 and headquartered in Lyon, France is one of the oldest and most respected actuarial institutes in the world training thousands of actuaries and performing cutting-edge research at the LABORATOIRE DE SCIENCES ACTUARIELLE & FINANCIERE (SAF). It frequently organizes international conferences and meetings bringing together actuaries from all over the world. In 2015, it hosted Longevity'11 actuarial conference with the Cass Business School.
Insilico Medicine recently published two papers demonstrating deep biomarkers of human aging and providing an overview of deep learning applications in biomedicine and expects more papers demonstrating applications of DL to drug discovery and biomarker development to be published shortly.
"While being very strict and conservative, actuarial science is a constantly evolving field and at ISFA we are constantly innovating introducing new technologies and computational methods, as well as fostering out of the box thinking. Deep learning demonstrated spectacular results in many areas and we invited scientists from Insilico Medicine to present their results in biomarker development and drug discovery and to discuss recent trends", said Dr. Stephane Loisel, professor at ISFA and co-organizer of the ISFA-Columbia workshop.
The registration deadline for the event is June 15th and actuaries, insurance and pension funds managers and other financial professionals are encouraged to register and attend the event.
"We are entering a new era in actuarial science, when advances big data analytics and artificial intelligence in concert with better understanding of many biological processes will transform the way we look at risk, build models and make predictions. This conference will be a major milestone in this new era and I encourage everyone in actuarial science and financial engineering to attend", said Edouard Debonneuil, CEO of ActuRx and researcher at ISFA.
###
About Insilico Medicine
Insilico Medicine, Inc. is a bioinformatics company located at the Emerging Technology Centers at the Johns Hopkins University Eastern campus in Baltimore with R&D resources in Belgium, Russia and Poland hiring talent through hackathons and competitions. It utilizes advances in genomics, big data analysis and deep learning for in silico drug discovery and drug repurposing for aging and age-related diseases. The company pursues internal drug discovery programs in cancer, Parkinson's, Alzheimer's, sarcopenia and geroprotector discovery. Through its Pharma.AI division the company provides advanced machine learning services to biotechnology, pharmaceutical and skin care companies. Brief company video: https://www.youtube.com/watch?v=l62jlwgL3v8
ABOUT INSTITUT DE SCIENCE FINANCIERE ET D'ASSURANCES (ISFA)
The Institute for Financial Science and Insurance was founded in Lyon-France in 1930. This is one of the oldest institutes providing a large output of actuaries with the major financial and insurance companies.
Graduate school of University Claude Bernard Lyon 1, ISFA is one of the best actuarial education institutions in Europe. I.S.F.A. actuarial degree is fully accredited by the Institut des Actuaires, member of International Actuarial Association - IAA. Website: http://isfa.univ-lyon1.fr